Walleye Capital’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-70,154
Closed -$546K 4802
2024
Q3
$546K Buy
+70,154
New +$507K ﹤0.01% 3219
2024
Q1
Sell
-33,595
Closed -$263K 5390
2023
Q4
$263K Buy
33,595
+13,459
+67% +$93.3K ﹤0.01% 3477
2023
Q3
$147K Sell
20,136
-10,486
-34% -$87.2K ﹤0.01% 3747
2023
Q2
$319K Buy
+30,622
New +$295K ﹤0.01% 2743
2023
Q1
Sell
-11,474
Closed -$158K 3905
2022
Q4
$158K Buy
+11,474
New +$160K ﹤0.01% 2185

Other funds holding ANGO

Walleye Capital's ANGO Position: Q4 2024 in Review

Walleye Capital sold out of AngioDynamics (ANGO) in Q4 2024, closing a stake of 70,154 shares — an estimated $546K sold.

Walleye Capital first reported a position in ANGO in Q4 2022 and held it in 5 quarters. The position peaked at $546K in Q3 2024. 135 funds tracked by Wall St. Rank hold ANGO as of Q4 2024.

  • Walleye Capital reported no remaining AngioDynamics position as of Q4 2024 after selling out during the quarter.
  • Walleye Capital sold 70,154 AngioDynamics shares in Q4 2024, an estimated $546K.
  • Walleye Capital first reported a position in AngioDynamics in Q4 2022 and held it in 5 quarters.
  • Walleye Capital's AngioDynamics position peaked at $546K in Q3 2024.
  • 135 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2024.

Based on Walleye Capital's 13F filing for Q4 2024, filed 13 Feb 2025.